COsegregation of VARiants in Panel of Genes
NCT01689584 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3500
Last updated 2025-04-06
Summary
The aim of the COVAR project is to classify reliably a maximum of VUS of the French database in order to use them for the genetic counseling. The results obtained through this study will have a major impact on clinical management of the patients and their families conducting in some cases to propose a prophylactic surgery.
Conditions
- Gene Mutation-Related Cancer
- Genetic Predisposition
Interventions
- GENETIC
-
salivary kit
The saliva samples will be made of selected related (DNA).
Sponsors & Collaborators
-
Institut Curie
lead OTHER
Principal Investigators
-
Dominique STOPPA-LYONNET, PU-PH · Institut Curie
-
Sandrine CAPUTO, PhD · Institut Curie
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-02
- Primary Completion
- 2033-01-02
- Completion
- 2034-01-02
Countries
- France
- Guadeloupe
- Martinique
- Reunion
Study Locations
More Related Trials
-
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
NCT06489041 ·Status: RECRUITING ·Phase: NA
-
Choices About Genetic Testing And Learning Your Risk With Smart Technology
NCT06184867 ·Status: COMPLETED ·Phase: NA
-
Michigan Genetic Hereditary Testing (MiGHT)
NCT05162846 ·Status: COMPLETED ·Phase: NA
-
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
NCT00003329 ·Status: COMPLETED
-
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
NCT02664389 ·Status: TERMINATED ·Phase: NA
-
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
NCT04258137 ·Status: RECRUITING ·Phase: NA
-
Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
NCT05583422 ·Status: COMPLETED
-
Universal Genetic Testing for Cancer Risk Reduction
NCT06926816 ·Status: RECRUITING ·Phase: NA
-
Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
NCT06559033 ·Status: NOT_YET_RECRUITING
-
Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment
NCT06800599 ·Status: ENROLLING_BY_INVITATION
-
Combating the Diagnostic Impasse in Mitochondrial Diseases: a Transcriptomic Approach in Fibroblasts and Blood Cells
NCT06621732 ·Status: RECRUITING ·Phase: NA
-
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
NCT04576858 ·Status: UNKNOWN
-
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
NCT03265496 ·Status: TERMINATED ·Phase: NA
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144 ·Status: COMPLETED ·Phase: NA
-
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
NCT06060561 ·Status: SUSPENDED
-
Oncology Research Information Exchange Network in Improving Genetic Screening Rate in Patients With Cancer
NCT03348137 ·Status: WITHDRAWN
-
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614 ·Status: UNKNOWN
-
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
NCT01334008 ·Status: COMPLETED ·Phase: NA
-
Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer
NCT02823652 ·Status: COMPLETED ·Phase: NA
-
IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
NCT05014698 ·Status: TERMINATED ·Phase: NA
-
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
NCT05420064 ·Status: RECRUITING ·Phase: NA
-
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
NCT03414827 ·Status: RECRUITING
-
Physicians Survey on Genetic Testing
NCT00341107 ·Status: COMPLETED
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Genetic Variants and Chemotherapy-induced Abnormal Thermal Sensation
NCT03252834 ·Status: TERMINATED